09.21.12
A placebo-controlled, randomized double-blind clinical trial published in Phytotherapy Research titled “Effects of Supplementation with Curcuminoids on Dyslipidemia in Obese Patients: A Randomized Crossover Trial”(Mohammadi et al, 2012) reported that Sabinsa’s Curcumin C3 Complex led to a significant reduction in serum triglycerides concentration in a randomized crossover clinical trial. Thirty participants received curcuminoids (1g/day) with natural bioavailability-enhancer BioPerine, or placebo. Serum concentrations of total cholesterol, triglycerides, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, together with anthropometric parameters and high-sensitivity C-reactive protein were measured before and after each treatment period. Serum triglycerides were significantly reduced following curcumin supplementation (first period 105.7 à 95.1 mg/dL, and second period 120.7 à 104.7 mg/dL). The findings of the present study indicated that curcuminoids supplementation (1g/day for 30 days) leads to a significant reduction in serum triglycerides concentrations.
For more information: www.curcuminoids.com
For more information: www.curcuminoids.com
